Quant Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 11-09-2026
NAV ₹18.25(R) -0.25% ₹19.22(D) -0.24%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 16.7% 18.94% -% -% -%
Direct 18.59% 20.9% -% -% -%
Nifty Pharma TRI 20.11% 20.92% 13.86% 19.36% 9.36%
SIP (XIRR) Regular 31.61% 15.58% -% -% -%
Direct 33.71% 17.45% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 379 Cr
Top Pharma Fund
Fund Name Rank Rating
SBI Healthcare Opportunities Fund -
UTI Healthcare Fund -
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
DSP Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -
Mirae Asset Healthcare Fund -
Nippon India Pharma Fund -
Tata India Pharma & Healthcare Fund -

NAV Date: 11-09-2026

Scheme Name NAV Rupee Change Percent Change
quant Healthcare Fund - Growth Option - Regular Plan 18.25
-0.0500
-0.2500%
quant Healthcare Fund - IDCW Option - Regular Plan 18.25
-0.0500
-0.2500%
quant Healthcare Fund - Growth Option - Direct Plan 19.22
-0.0500
-0.2400%
quant Healthcare Fund - IDCW Option - Direct Plan 19.22
-0.0500
-0.2400%

Review Date: 11-09-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 1.79 -0.81
-0.26
-3.52 | 2.61 2 | 17 Very Good
3M Return % 13.13 9.43
9.95
3.71 | 14.57 3 | 17 Very Good
6M Return % 24.08 14.04
18.81
10.31 | 25.91 4 | 17 Very Good
1Y Return % 16.70 20.11
16.37
5.48 | 26.06 8 | 16 Good
3Y Return % 18.94 20.92
20.38
17.52 | 22.97 8 | 10 Average
1Y SIP Return % 31.61
27.85
10.89 | 41.93 7 | 16 Good
3Y SIP Return % 15.58
15.94
11.98 | 20.33 6 | 10 Good
Return data last Updated On : Sept. 11, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 1.93 -0.81 -0.16 -3.47 | 2.74 2 | 17 Very Good
3M Return % 13.59 9.43 10.31 3.91 | 15.06 3 | 17 Very Good
6M Return % 25.10 14.04 19.62 10.78 | 26.98 4 | 17 Very Good
1Y Return % 18.59 20.11 17.96 6.34 | 28.09 8 | 16 Good
3Y Return % 20.90 20.92 21.86 18.57 | 24.25 8 | 10 Average
1Y SIP Return % 33.71 29.55 11.75 | 44.14 7 | 16 Good
3Y SIP Return % 17.45 17.36 13.33 | 21.55 5 | 10 Good
Return data last Updated On : Sept. 11, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Quant Healthcare Fund NAV Regular Growth Quant Healthcare Fund NAV Direct Growth
11-09-2026 18.2529 19.2174
10-09-2026 18.2983 19.2644
09-09-2026 18.3632 19.3319
08-09-2026 18.4904 19.4649
07-09-2026 18.4909 19.4646
04-09-2026 18.2274 19.1846
03-09-2026 18.3029 19.2632
02-09-2026 18.3475 19.3093
01-09-2026 18.4439 19.4098
31-08-2026 18.452 19.4176
28-08-2026 18.4547 19.4178
27-08-2026 18.3844 19.3429
26-08-2026 18.3049 19.2584
25-08-2026 18.107 19.0494
24-08-2026 18.0414 18.9795
21-08-2026 17.9991 18.9325
20-08-2026 18.144 19.084
19-08-2026 18.0878 19.0241
18-08-2026 18.0461 18.9794
17-08-2026 17.936 18.8628
14-08-2026 17.7762 18.6922
13-08-2026 17.9313 18.8544
12-08-2026 17.9174 18.839
11-08-2026 17.932 18.8535

Fund Launch Date: 17/Jul/2023
Fund Category: Pharma Fund
Investment Objective: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.
Fund Description: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.
Fund Benchmark: BSE Healthcare TRI
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.